Source:http://linkedlifedata.com/resource/pubmed/id/16895946
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-9-26
|
pubmed:abstractText |
Nitrofurans are widely used in human medicine, as nitrofurantoin and nifuroxazide, still prescribed for long-term antimicrobial prophylaxis of urinary tract and gastrointestinal infection in humans respectively. Recent experiments in mammals, as well as reports mentioning toxic effects in humans associated with a long-term use, specially in the case of nitrofurantoin, raised the need for reevaluating their genotoxicity. The objective of this study was to determine whether these two compounds induce a mutagenic effect in the Big Blue transgenic mouse mutation assay. Mice were orally treated either with nitrofurantoin or nifuroxazide for five consecutive days and sacrificed 3 weeks later. In order to optimize the genotoxic response, the doses used for each compound were 25-fold higher as the posology in humans. They corresponded to 50% of the highest doses tolerated by mice. The mutant frequency was determined from kidney, lung, bladder, caecum, colon, small intestine, spleen and stomach. A weak mutagenic response of nitrofurantoin-treated mice specifically in the kidney was observed. As in the case of other nitrofuran compounds, the mutation spectra determined from treated samples exhibited slightly more GC-->TA transversions as compared with untreated conditions. These data are relevant to the targeted action of nitrofurantoin as a urinary antimicrobial agent. No significant increase of mutants was detected in the case of nifuroxazide-treated mice whatever the organs analysed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0267-8357
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-11
|
pubmed:meshHeading |
pubmed-meshheading:16895946-Animals,
pubmed-meshheading:16895946-DNA Damage,
pubmed-meshheading:16895946-Gastrointestinal Tract,
pubmed-meshheading:16895946-Hydroxybenzoic Acids,
pubmed-meshheading:16895946-Kidney,
pubmed-meshheading:16895946-Lung,
pubmed-meshheading:16895946-Male,
pubmed-meshheading:16895946-Mice,
pubmed-meshheading:16895946-Mice, Inbred C57BL,
pubmed-meshheading:16895946-Mice, Transgenic,
pubmed-meshheading:16895946-Mutagenicity Tests,
pubmed-meshheading:16895946-Mutation,
pubmed-meshheading:16895946-Nitrofurans,
pubmed-meshheading:16895946-Nitrofurantoin,
pubmed-meshheading:16895946-Organ Specificity
|
pubmed:year |
2006
|
pubmed:articleTitle |
Organ-targeted mutagenicity of nitrofurantoin in Big Blue transgenic mice.
|
pubmed:affiliation |
Unité des Cyanobactéries, Institut Pasteur 28, Rue du Dr Roux, 75724 Paris Cedex15, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|